Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive Cough

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients \> 40 years of age, in our outpatient clinic with chronic cough and COPD (gold2-4)~* Chronic cough is defined as a cough \> 12 weeks duration, at least 12 weeks a year in 2 subsequent years.~* Analysed for bronchiectasis prior to participation by CT-thorax.~Exclusion Criteria:~* Prior history of asthma~* Use of i.v. or oral corticosteroids and or antibiotics for an exacerbation 3 weeks before inclusion~* Patients suffering from other relevant lung diseases.~* Clinically relevant abnormal laboratory values suggesting an unknown disease requiring further clinical evaluation.~* Liver disease, (ALAT and/or ASAT levels two or more times the upper limit of normal).~* Pregnancy or lactation.~* Use of macrolides the last 6 weeks prior to inclusion.~* Allergy or intolerance to macrolides.~* Other research medication started 2 months prior to inclusion.~* Prior randomisation in this study.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Azithromycin (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).